Department of Medicine, Respiratory and Critical Care Divisions, University of British Columbia, Vancouver, BC, Canada; Canadian Sleep and Circadian Network, Canada.
Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Canadian Sleep and Circadian Network, Canada.
Sleep Med. 2020 Oct;74:92-98. doi: 10.1016/j.sleep.2020.05.001. Epub 2020 May 11.
Distinct symptom subtypes are found in patients with OSA. The association between these subtypes and neurocognitive function is unclear.
The purposes of this study were to assess whether OSA symptom subtypes are present in a cohort of Canadian patients with suspected OSA and evaluate the relationship between subtypes and neurocognitive function.
Patients with suspected OSA who completed a symptom questionnaire and underwent testing for OSA were included. Symptom subtypes were identified using latent class analysis. Associations between subtypes and neurocognitive outcomes (Montreal Cognitive Assessment [MoCA], Rey Auditory Verbal Learning Test [RAVLT], Wechsler Adult Intelligence Scale [WAIS-IV], Digit-Symbol Coding subtest [DSC]) were assessed using analysis of covariance (ANCOVA), controlling for relevant covariates.
Four symptom subtypes were identified in patients with OSA (oxygen desaturation index ≥5 events/hour). Three were similar to prior studies, including the Excessively Sleepy (N=405), Disturbed Sleep (N=382) and Minimally Symptomatic (N=280), and one was a novel subtype in our sample defined as Excessively Sleepy with Disturbed Sleep (N=247). After covariate adjustment, statistically significant differences among subtypes (p=0.037) and among subtypes and patients without OSA (p=0.044) were observed in DSC scores; the Minimally Symptomatic subtype had evidence of higher DSC scores than all other groups, including non-OSA patients. No differences were seen in MoCA or RAVLT.
Results support the existence of previously identified OSA symptom subtypes of excessively sleepy, disturbed sleep and minimally symptomatic in a clinical sample from Canada. Subtypes were not consistently associated with neurocognitive function across multiple instruments.
阻塞性睡眠呼吸暂停(OSA)患者存在不同的症状亚型。这些亚型与神经认知功能之间的关系尚不清楚。
本研究旨在评估在加拿大疑似 OSA 患者队列中是否存在 OSA 症状亚型,并评估亚型与神经认知功能之间的关系。
纳入完成症状问卷并接受 OSA 检测的疑似 OSA 患者。使用潜在类别分析确定症状亚型。使用协方差分析(ANCOVA)评估亚型与神经认知结果(蒙特利尔认知评估 [MoCA]、瑞文听觉言语学习测验 [RAVLT]、韦氏成人智力量表 [WAIS-IV]、数字符号编码子测验 [DSC])之间的关联,同时控制相关协变量。
在 OSA 患者中确定了 4 种症状亚型(每小时氧减指数≥5 次)。其中 3 种与既往研究相似,包括过度嗜睡(N=405)、睡眠障碍(N=382)和轻度症状(N=280),另一种是我们样本中的新型亚型,定义为伴有睡眠障碍的过度嗜睡(N=247)。经过协变量调整后,在 DSC 评分方面,亚型之间(p=0.037)和亚型与无 OSA 患者之间(p=0.044)存在统计学差异;轻度症状亚型的 DSC 评分明显高于其他所有组,包括非 OSA 患者。在 MoCA 或 RAVLT 方面未观察到差异。
结果支持在加拿大临床样本中存在先前确定的 OSA 过度嗜睡、睡眠障碍和轻度症状的症状亚型。亚型与多种神经认知功能测试之间并未始终相关。